Protein Adducts as Biomarkers for Chemical Carcinogens

  • Paul L. Skipper
  • Steven R. Tannenbaum
Part of the Environmental Science Research book series (ESRH, volume 39)


Protein adducts are one of several types of biomarkers which are valuable to the study of chemical carcinogenesis (8). Over the last 15 years, a great deal of developmental work has gone into making this particular biomarker a useful one. Much of the effort has been focused on hemoglobin as the target protein, but serum albumin has also proven interesting. Enough laboratory experiments and studies of human subjects have now been conducted that it is worthwhile to reflect on the results to attempt an assessment of the role protein adducts can play in the study of chemical carcinogenesis. This chapter specifically addresses issues related to epidemiological studies.


Polycyclic Aromatic Hydrocarbon Environmental Tobacco Smoke Systemic Dose Adduct Level Protein Adduct 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bailey, E., A.G.F. Brooks, C.T. Dollery, P.B. Farmer, B.J. Passingham, M.A. Sleightholm, and D.W. Yates (1988) Hydroxyethylvaline adduct formation in haemoglobin as a biological monitor of cigarette smoke intake. Arch. Tox. 62:247–253.CrossRefGoogle Scholar
  2. 2.
    Bryant, M.S., P.L. Skipper, S.R. Tannenbaum, and M. Maclure (1987) Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res. 47:602–608.PubMedGoogle Scholar
  3. 3.
    Bryant, M.S., P. Vineis, P.L. Skipper, and S.R. Tannenbaum (1988) Hemoglobin adducts of aromatic amines: Associations with smoking status and type of tobacco. Proc. Natl. Acad. Sci., USA 85:9788–9791.PubMedCrossRefGoogle Scholar
  4. 4.
    Conney, A.H. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes memorial lecture. Cancer Res. 42:4875–4917.PubMedGoogle Scholar
  5. 5.
    Ehrenberg, L., K.D. Hiesche, S. Osterman-Golkar, and I. Wennberg (1974) Evaluation of genetic risks of alkylating agents: Tissue doses in the mouse from air contaminated with ethylene oxide. Mutat. Res. 24:83–103.Google Scholar
  6. 6.
    Gan, L.-S., M.S. Otteson, M.M. Doxtader, P.L. Skipper, R.R. Dasari, and S.R. Tannenbaum (1989) Quantitation of carcinogen bound protein adducts by fluorescence measurements. Spectrochimica ACTA 45A:81–86.Google Scholar
  7. 7.
    Gan, L.-S., P.L. Skipper, X. Peng, J.D. Groopman, J.-s. Chen, G.N. Wogan, and S.R. Tannenbaum (1988) Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: Correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis 9:1323–1325.PubMedCrossRefGoogle Scholar
  8. 8.
    Harris, C.C., A. Weston, J.C. Willey, G.E. Trivers, and D.L. Mann (1987) Biochemical and molecular epidemiology of human cancer: Indicators of carcinogen exposure, DNA damage, and genetic predisposition. Env. Health Persp. 75:109–119.CrossRefGoogle Scholar
  9. 9.
    Hill, P., N.J. Haley, and E.L. Wynder (1983) Cigarette smoking: Carboxy-hemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. J. Chron. Pis. 36:439–449.CrossRefGoogle Scholar
  10. 10.
    Kadlubar, F.F., K.L. Dooley, G. Talaska, D.R. Roberts, F.A. Beland, C.H. Teitel, J.F. Young, P.L. Skipper, S.R. Tannenbaum, G.D. Stoner, and N. Shivapurkar (1988) Determinants of susceptibility to adduct formation after multiple dosing with 4-aminobiphenyl. Proc. Am. Assn. Cancer Res. 29:354.Google Scholar
  11. 11.
    Maclure, M., R.B.A. Katz, M.S. Bryant, P.L. Skipper, and S.R. Tannenbaum (1989) Elevated blood levels of carcinogens in passive smokers. Am. J. Pub. Health (in press).Google Scholar
  12. 12.
    Maclure, M., M.S. Bryant, P.L, Skipper, and S.R. Tannenbaum (1990) Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking. Cancer Res, (in press).Google Scholar
  13. 13.
    National Research Council Committee on Biological Markers (1987) Biological markers in environmental health research. Env. Health Persp. 74:3–9.Google Scholar
  14. 14.
    Patrianakos, C, and D. Hoffman (1979) Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke. J. Analyt. Tox. 3:149–154.Google Scholar
  15. 15.
    Sabbioni, G., P.L. Skipper, and S.R. Tannenbaum (1987) Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis 8:819–824.PubMedCrossRefGoogle Scholar
  16. 16.
    Skipper, P.L., S.N. Naylor, L.-S. Gan, B.W. Day, R. Pastorelli, and S.R. Tannenbaum (1989) Origin of the tetrahydrotetrols derived from human hemoglobin adducts of benzo(a)pyrene. Chem. Res. in Tox. 2:280–281.CrossRefGoogle Scholar
  17. 17.
    Tannenbaum, S.R., M.S. Bryant, P.L. Skipper, and M. Maclure (1986) Hemoglobin adducts of tobacco-related aromatic amines: Application to molecular epidemiology. In Banbury Report 23: Mechanisms in Tobacco Carcinogenesis, D. Hoffmann and C.C. Harris, eds., Cold Spring Harbor Laboratory, New York, pp. 63–75.Google Scholar
  18. 18.
    Turesky, R.J., P.L. Skipper, and S.R. Tannenbaum (1987) Binding of 2-amino-3-methylimidazo[4,5-f]quinoline to hemoglobin and albumin in vivo in the rat. Identification of an adduct suitable for dosimetry. Carcinogenesis 8:1537–1542.PubMedCrossRefGoogle Scholar
  19. 19.
    Vineis, P., J. Esteve, and B. Terracini (1984) Bladder cancer and smoking in males: Types of cigarettes, age at start, effect of stopping and interaction with occupation. Int. J. Cancer 34:165–170.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Paul L. Skipper
    • 1
  • Steven R. Tannenbaum
    • 1
  1. 1.Division of ToxicologyMassachusetts Institute of TechnologyCambridgeUSA

Personalised recommendations